Hot AXIOS™ for Bile Duct Drainage in Malignant Stenosis
- Conditions
- Malignant Biliary Stenosis
- First Posted Date
- 2024-12-27
- Last Posted Date
- 2025-06-24
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 162
- Registration Number
- NCT06750146
- Locations
- 🇫🇷
CHU de Besançon, Besançon, France
🇫🇷Clinique des Cedres, Ramsay Sante, Cornebarrieu, France
🇫🇷CHU Limoges, Limoges, France
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
- Conditions
- Persistent Atrial Fibrillation
- First Posted Date
- 2024-12-16
- Last Posted Date
- 2025-06-25
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 407
- Registration Number
- NCT06735534
- Locations
- 🇺🇸
Arrhythmia Research Group-Research Facility, Jonesboro, Arkansas, United States
cOncomitant Left Atrial aPpendage Closure and Pulsed Field ablaTION-Asia
- Conditions
- Concomitant ProceduresAtrial FibrillationPFALAAC
- First Posted Date
- 2024-11-13
- Last Posted Date
- 2025-06-04
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 433
- Registration Number
- NCT06686485
- Locations
- 🇨🇳
Beijing Anzhen Hospital of the Capital University of Medical Sciences, Beijing, China
🇲🇾Institute Jantung Negara, Kuala Lumpur, Malaysia
RIVOS Feasibility (MBO)
- Conditions
- Malignant Biliary Obstruction
- First Posted Date
- 2024-10-31
- Last Posted Date
- 2025-06-12
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 20
- Registration Number
- NCT06666699
- Locations
- 🇧🇪
Ghent University Hospital, Ghent, Belgium
🇫🇷Georges Pompidou European Hospital, Paris, France
🇮🇳Asian Institute of Gastroenterology, Hyderabad, Telangana, India
FARAPULSE Workflow Assessment Registry
- Conditions
- Atrial Fibrillation (AF)
- First Posted Date
- 2024-10-24
- Last Posted Date
- 2025-06-20
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 500
- Registration Number
- NCT06656884
- Locations
- 🇩🇪
Munchen Klinik Bogenhausen, München, Germany
🇦🇹A.o. Krankenhaus der Elisabethinen Linz, Linz, Austria
🇧🇪Ziekenhuis aan de Stroom, Middelheim, Antwerp, Belgium
A Prospective, Multi-center Study to Evaluate Efficacy and Safety of BSJ020R in Treatment of AVF for Hemodialysis (RANGER AV Japan Study)
- Conditions
- Arteriovenous Fistula StenosisArteriovenous FistulaVascular Access
- First Posted Date
- 2024-10-15
- Last Posted Date
- 2025-06-12
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 186
- Registration Number
- NCT06639451
- Locations
- 🇯🇵
Kansai Rosai Hospital, Amagasaki, Hyogo, Japan
🇯🇵Yokohama Dai-ichi Hospital, Yokohama, Kanagawa, Japan
🇯🇵Kishiwada Tokushukai Hospital, Kishiwada, Osaka, Japan
Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS
- Conditions
- Movement DisordersParkinson DiseaseDystoniaEssential Tremor
- Interventions
- Device: Radiofrequency Ablation
- First Posted Date
- 2024-08-14
- Last Posted Date
- 2025-06-08
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 200
- Registration Number
- NCT06553625
- Locations
- 🇩🇪
Uniklinik Köln, Cologne, Germany
🇩🇪Universitaetsklinikum Dusseldorf, Dusseldorf, Germany
🇬🇧St. Georges Hospital, London, United Kingdom
ADVENT Trial Long Term Outcomes Evaluating Atrial Fibrillation Progression Study
- Conditions
- Paroxysmal Atrial Fibrillation
- First Posted Date
- 2024-07-30
- Last Posted Date
- 2025-06-29
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 583
- Registration Number
- NCT06526546
- Locations
- 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States
🇺🇸Grandview Medical Center, Birmingham, Alabama, United States
🇺🇸Banner University Medical Center Phoenix, Phoenix, Arizona, United States
SIMPLAAFY Clinical Trial
- Conditions
- StrokeBleedingAtrial Fibrillation
- Interventions
- Device: WATCHMAN FLX Pro LAAC Device
- First Posted Date
- 2024-07-26
- Last Posted Date
- 2025-06-17
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 1857
- Registration Number
- NCT06521463
- Locations
- 🇺🇸
University of Alabama Birmingham, Birmingham, Alabama, United States
🇺🇸Grandview Medical Center, Birmingham, Alabama, United States
🇺🇸Phoenix Cardiovascular Research Group, Phoenix, Arizona, United States
Feasibility Study of the FARAFLEX Mapping and PFA System
- Conditions
- Atrial FibrillationPersistent Atrial Fibrillation
- Interventions
- Device: Ablation Treatment
- First Posted Date
- 2024-07-19
- Last Posted Date
- 2025-06-06
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 100
- Registration Number
- NCT06510556
- Locations
- 🇨🇿
Nemocnice Na Homolce Hospital, Prag, Czechia
🇭🇷Klinicki bolnicki centar Split, Split, Croatia